ATE393216T1 - Formulierungen vernetzter proteinkristalle und ihre verwendung als katalysatoren in organischen lösungsmitteln - Google Patents

Formulierungen vernetzter proteinkristalle und ihre verwendung als katalysatoren in organischen lösungsmitteln

Info

Publication number
ATE393216T1
ATE393216T1 AT97925652T AT97925652T ATE393216T1 AT E393216 T1 ATE393216 T1 AT E393216T1 AT 97925652 T AT97925652 T AT 97925652T AT 97925652 T AT97925652 T AT 97925652T AT E393216 T1 ATE393216 T1 AT E393216T1
Authority
AT
Austria
Prior art keywords
catalysts
formulations
cross
organic solvents
linked protein
Prior art date
Application number
AT97925652T
Other languages
German (de)
English (en)
Inventor
Nazer Khalaf
Original Assignee
Altus Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altus Pharmaceuticals Inc filed Critical Altus Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE393216T1 publication Critical patent/ATE393216T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AT97925652T 1996-05-24 1997-05-20 Formulierungen vernetzter proteinkristalle und ihre verwendung als katalysatoren in organischen lösungsmitteln ATE393216T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/652,964 US5932212A (en) 1996-05-24 1996-05-24 Crosslinked protein crystal formulations and their use as catalysts in organic solvents

Publications (1)

Publication Number Publication Date
ATE393216T1 true ATE393216T1 (de) 2008-05-15

Family

ID=24618946

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97925652T ATE393216T1 (de) 1996-05-24 1997-05-20 Formulierungen vernetzter proteinkristalle und ihre verwendung als katalysatoren in organischen lösungsmitteln

Country Status (13)

Country Link
US (2) US5932212A (enExample)
EP (1) EP0906417B1 (enExample)
JP (2) JP4279351B2 (enExample)
KR (1) KR20000015993A (enExample)
AR (1) AR007211A1 (enExample)
AT (1) ATE393216T1 (enExample)
AU (1) AU3072897A (enExample)
DE (1) DE69738648T2 (enExample)
DK (1) DK0906417T3 (enExample)
ID (1) ID17817A (enExample)
IN (1) IN191060B (enExample)
WO (1) WO1997044445A1 (enExample)
ZA (1) ZA974325B (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009750A1 (en) * 1990-11-29 1992-06-11 Willis Richard R Floating contaminant containment systems
US6140475A (en) * 1997-04-11 2000-10-31 Altus Biologics Inc. Controlled dissolution crosslinked protein crystals
AU747022B2 (en) * 1997-06-20 2002-05-09 New York University Electrospraying solutions of substances for mass fabrication of chips and libraries
US6833275B1 (en) * 1997-07-22 2004-12-21 Roche Diagnostics Gmbh Gold conjugates containing detergent
US6500933B1 (en) 1997-09-05 2002-12-31 Altus Biologics Inc. Methods of preparing carbohydrate crosslinked glycoprotein crystals
DK1009759T3 (da) * 1997-09-05 2008-08-04 Altus Pharmaceuticals Inc Carbohydrat-tværbundne glycoproteinkrystaller
ZA988461B (en) * 1997-09-18 1999-03-30 Idec Pharma Corp Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis
US6541606B2 (en) * 1997-12-31 2003-04-01 Altus Biologics Inc. Stabilized protein crystals formulations containing them and methods of making them
SG121739A1 (en) * 1998-04-27 2006-05-26 Altus Pharmaceuticals Inc Stabilized protein crystals, formulations containing them and methods of making them
US6979561B1 (en) 1998-10-09 2005-12-27 Gilead Sciences, Inc. Non-homogeneous systems for the resolution of enantiomeric mixtures
RU2247779C2 (ru) * 1998-10-09 2005-03-10 Элтус Байолоджикс Инк. Способ получения нерацемических сложного эфира и спирта, а также двухфазная негомогенная система для его осуществления
DE19903125B4 (de) * 1999-01-27 2006-01-05 Sanofi-Aventis Deutschland Gmbh Verfahren zur Trocknung von Kristallen von Insulin oder Insulinanaloga
AU6574400A (en) * 1999-08-18 2001-03-13 Hydrios Biotechnology Oy Process for the preparation and simultaneous separation of enzyme-catalysed products
US7300775B2 (en) 1999-12-29 2007-11-27 Verenium Corporation Methods for producing α-substituted carboxylic acids using nitrilases and strecker reagents
US20040014195A1 (en) * 1999-12-29 2004-01-22 Diversa Corporation Nitrilases, nucleic acids encoding them and methods for making and using them
US7608445B1 (en) 1999-12-29 2009-10-27 Verenium Corporation Nitrilases, nucleic acids encoding them and methods for making and using them
US7521216B2 (en) 1999-12-29 2009-04-21 Verenium Corporation Nitrilases and methods for making and using them
US20010046493A1 (en) * 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
WO2001090733A1 (en) * 2000-05-23 2001-11-29 Radiometer Medical A/S A sensor membrane, a method for the preparation thereof, a sensor and a layered membrane structure for such sensor
EP2325205A3 (en) 2000-12-28 2011-10-12 Altus Pharmaceuticals Inc. Crystals of whole antibodies and fragments thereof and methods for making and using them
EP1492554B1 (en) 2001-06-21 2019-08-21 Althea Technologies, Inc. Spherical protein particles
US7932064B2 (en) 2002-06-13 2011-04-26 Verenium Corporation Processes for making (R)-ethyl 4-cyano-3-hydroxybutyric acid
US9035123B2 (en) 2002-10-01 2015-05-19 The Procter & Gamble Company Absorbent article having a lotioned topsheet
JP2006523609A (ja) * 2002-12-31 2006-10-19 アルタス ファーマシューティカルズ インコーポレイテッド タンパク質結晶およびイオン性ポリマーの複合体
AU2003303646B2 (en) * 2002-12-31 2010-03-04 Altus Pharmaceuticals Inc. Human growth hormone crystals and methods for preparing them
EP1699921B1 (en) * 2004-01-01 2009-11-04 Council of Scientific and Industrial Research;an Indian Reg. body incorporated under Reg. of Societies Act (Act XXI of 1860) A method for the preparation of cross linked protein crystals
DE602005022471D1 (de) * 2004-10-14 2010-09-02 Altus Pharmaceuticals Inc Zusammensetzungen enthaltend lipase, protease und amylase zur behandlung von pankreasinsuffizienz
WO2007050100A2 (en) * 2004-11-24 2007-05-03 Industrial Science & Technology Network, Inc. Immobilized enzymes and processes for preparing and using same
US20060223765A1 (en) * 2005-03-30 2006-10-05 Kimberly-Clark Worldwide, Inc. Method for inhibiting and/or treating vaginal infection
GB0513888D0 (en) * 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
US20100196344A1 (en) * 2005-10-14 2010-08-05 Cystic Fibrosis Foundation Therapeutics, Inc. Compositions and methods for treating pancreatic insufficiency
EP1976551A4 (en) * 2005-12-23 2009-12-30 Altus Pharmaceuticals Inc COMPOSITIONS COMPRISING COMPLEX PROTEIN CRYSTALS BY POLYCATIONS AND PROCESSING METHOD THEREOF
US20100047413A1 (en) * 2006-09-15 2010-02-25 Cabalka Tourtellotte Leanne M Method of using amphiphilic multiblock copolymers in food
CA2679503A1 (en) 2007-03-01 2008-09-04 Verenium Corporation Nitrilases, nucleic acids encoding them and methods for making and using them
IL183084A0 (en) * 2007-05-09 2007-09-20 Trans Biodisel Ltd Modified-immobilized enzymes of high tolerance to hydrophilic substrates in organic media
CN101717766B (zh) * 2009-12-01 2012-07-18 暨南大学 蛋白质酶的微水介质固定化方法
CA2803959C (en) 2010-06-30 2021-01-19 Codexis, Inc. Chemically modified carbonic anhydrases useful in carbon capture systems
US9303255B2 (en) 2010-08-26 2016-04-05 Aisin Seiki Kabushiki Kaisha Electrode having enzyme crystals immobilized thereon, method for producing electrode having enzyme crystals immobilized thereon, and biological fuel cell and biosensor provided with electrode having enzyme crystals immobilized thereon

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267234A (en) * 1978-03-17 1981-05-12 California Institute Of Technology Polyglutaraldehyde synthesis and protein bonding substrates
US4369226A (en) * 1979-03-19 1983-01-18 California Institute Of Technology Polyglutaraldehyde synthesis and protein bonding substrates
US5152903A (en) * 1988-12-19 1992-10-06 American Cyanamid Company Cross-linked cationic polymeric microparticles
EP0550450B1 (en) * 1990-08-03 2003-05-14 Vertex Pharmaceuticals Incorporated Use of crosslinked crystals as a novel form of enzyme immobilization
GB9309243D0 (en) * 1993-05-05 1993-06-16 Allied Colloids Ltd Enzyme dispersions,their production and compositions containing them
ES2109698T3 (es) * 1993-05-20 1998-01-16 Loders Croklaan Bv Procedimiento para la preparacion de lipasas inmovilizadas.
JPH09506127A (ja) * 1993-12-03 1997-06-17 バックマン・ラボラトリーズ・インターナショナル・インコーポレーテッド ブロックコポリマーによる酵素安定化
DE4344211A1 (de) * 1993-12-23 1995-06-29 Basf Ag Verfahren zur Erhöhung der Aktivität von hydrolytischen Enzymen

Also Published As

Publication number Publication date
DE69738648D1 (de) 2008-06-05
US6042824A (en) 2000-03-28
JP2000514282A (ja) 2000-10-31
EP0906417B1 (en) 2008-04-23
EP0906417A1 (en) 1999-04-07
JP2008061652A (ja) 2008-03-21
KR20000015993A (ko) 2000-03-25
ZA974325B (en) 1997-12-18
DK0906417T3 (da) 2008-07-21
WO1997044445A1 (en) 1997-11-27
AU3072897A (en) 1997-12-09
ID17817A (id) 1998-01-29
AR007211A1 (es) 1999-10-13
US5932212A (en) 1999-08-03
DE69738648T2 (de) 2009-05-28
JP4279351B2 (ja) 2009-06-17
IN191060B (enExample) 2003-09-13

Similar Documents

Publication Publication Date Title
ATE393216T1 (de) Formulierungen vernetzter proteinkristalle und ihre verwendung als katalysatoren in organischen lösungsmitteln
DE69511860D1 (de) Modifizierung von clostridium-toxinen und ihre anwendung als transport proteine
DE59812907D1 (de) Substituierte Isochinolin-3-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
ATE277895T1 (de) 4-brom or 4-iod-phenylamino- benzhydroxamsäurederivate und ihre anwendung als mek-inhibitoren
DE59703869D1 (de) Aminothiophencarbonsäureamide und ihre verwendung als phosphodiesterase inhibitoren
DE69720389D1 (de) Zementzusammensetzungen und ihre Verwendung
DE69836346D1 (de) Heteroaryl aminoguanidin- und alkoxyguanidinderivate und ihre verwendung als proteasehemmer
ATE227266T1 (de) Aromatische c16-c20-substituierte tetrahydro- prostaglandine und ihre verwendung als prostaglandin f agonisten
DE59706602D1 (de) 3-Hydroxy-Pyridin-2-carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel
DE69718791D1 (de) Neuartige aminosäurederivate und deren verwendung als thrombininhibitoren
DE59804276D1 (de) Substituierte Aminoverbindungen und ihre Verwendung als analgetisch wirksame Substanzen
DE59708905D1 (de) Injektionsformulierungen von avermectinen und milbemycinen
DE69714504D1 (de) Benzothiopene, diese enthaltende Zubereitungen und Verfahren
DE69716896D1 (de) Substituierte benzylamine-derivate und ihre verwendung zur behandlung von depression
DE69825202D1 (de) Kautschukzusammensetzung und ihre Verwendung in Reifen
DE69620914D1 (de) Perfluoralkoxycycloalkancarbonylfluorid-zusammensetzungen und ihre verwendung
DE69822509D1 (de) Zusammensetzung von alditol-acetalen und ihrer verwendung
DE59701610D1 (de) Verwendung von sarkosinaten als asphalten-dispergatoren
ATE209626T1 (de) Alkyloxyamin-substituierte fluorenonderivate und ihre verwendung als proteinkinase-c-inhibitoren
DE59711049D1 (de) Kosmetisches Hautbräunungs- und Lichtschutzmittel
DE69832902D1 (de) Oromukosal-zytokin-zusammensetzungen und ihre verwendung
DE69728938D1 (de) Peptidantagonisten der zellulären mitogenese und motogenese und deren therapeutische verwendung
EP1073458A4 (en) CHLAMYDIA PROTEINS AND USES THEREOF
NO990806L (no) Biologisk nedbrytning av eksplosiver
DE69719750D1 (de) Kosmetische haarwaschmittel und ihre verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties